3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
103
Lymphoma
68
Lymphoma, Large B-Cell, Diffuse
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
41
Sarcoma
33
Lymphoma, Non-Hodgkin
29
Hodgkin Disease
28
Leukemia
23
Burkitt Lymphoma
22
Neoplasms
19
Lymphoma, Mantle-Cell
18
Triple Negative Breast Neoplasms
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, B-Cell
14
Lymphoma, Large-Cell, Anaplastic
12
Carcinoma, Hepatocellular
12
Breast Neoplasms, Male
11
Neuroblastoma
10
Recurrence
9
Ovarian Neoplasms
9
Neoplasm Metastasis
9
Inflammatory Breast Neoplasms
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, T-Cell
8
Osteosarcoma
7
Fallopian Tube Neoplasms
7
Urinary Bladder Neoplasms
6
Liposarcoma
6
Interventions
fludarabine phosphate
41
Peripheral Blood Stem Cell Transplantation
36
Cytarabine
32
Cyclophosphamide
31
Whole-Body Irradiation
30
Busulfan
30
Tacrolimus
28
Mycophenolic Acid
27
Methotrexate
18
Etoposide
18
Cyclosporine
18
Antilymphocyte Serum
16
Filgrastim
15
Melphalan
13
Granulocyte Colony-Stimulating Factor
11
Idarubicin
10
Flow Cytometry
9
Clofarabine
9
Daunorubicin
8
sargramostim
7
Radiotherapy
7
Mitoxantrone
7
Cord Blood Stem Cell Transplantation
7
Transplantation
6
Thiotepa
6
Sirolimus
6
merphos
5
fludarabine
5
aldesleukin
5
Vorinostat
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Congenital Abnormalities
×
Doxorubicin
×
Clear all
No trials found.